GWW
64
6
MDLZ
51
-2
M
48
-5
AIG
63
-2
BDX
61
2
NOV
45
-2
ALL
47
-3
AVGO
69
8
URBN
63
-3
ADI
70
2
D
53
2
APA
27
2
NOC
40
-3
SWK
64
-3
IVZ
65
3
PEG
57
2
SO
84
2
DVA
75
2
PSX
47
5
KHC
31
-2
GWW
64
6
MDLZ
51
-2
M
48
-5
AIG
63
-2
BDX
61
2
NOV
45
-2
ALL
47
-3
AVGO
69
8
URBN
63
-3
ADI
70
2
D
53
2
APA
27
2
NOC
40
-3
SWK
64
-3
IVZ
65
3
PEG
57
2
SO
84
2
DVA
75
2
PSX
47
5
KHC
31
-2
Financhill
Back

Takeda Pharmaceutical Quote, Financials, Valuation and Earnings

Sell
29

TAK
Takeda Pharmaceutical

Last Price:
13.32
Seasonality Move:
1.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Takeda Pharmaceutical Price Quote

$13.32
-0.07 (-0.52%)
(Updated: May 16, 2024 at 6:55 PM ET)

Takeda Pharmaceutical Key Stats

Sell
29
Takeda Pharmaceutical (TAK) is a Sell
Day range:
$13.27 - $13.35
52-week range:
$12.77 - $16.47
Dividend yield:
4.7%
P/E ratio:
42.39
P/S ratio:
1.43
P/B ratio:
0.87%
Volume:
1.1M
Avg. volume:
1.7M
1-year change:
-18.95%
Market cap:
$42B
Revenue:
$29.5B
EPS:
$0.32

How Much Does Takeda Pharmaceutical Make?

Is Takeda Pharmaceutical Growing As A Company?

  • What Is Takeda Pharmaceutical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.02%
  • What Is Takeda Pharmaceutical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.16%

Takeda Pharmaceutical Stock Price Performance

What Is Takeda Pharmaceutical 52-Week High & Low?

Takeda Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Takeda Pharmaceutical?

Is Takeda Pharmaceutical Cash Flow Positive?

  • What Is TAK Cash Flow From Operations?
    Cash flow from operations (TTM) is $5B
  • What Is Takeda Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$2.5B
  • What Is Takeda Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$3.2B

Takeda Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    TAK return on invested capital is 1.27%
  • What Is Takeda Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 1%
  • What Is TAK Return On Equity?
    ROE is a measure of profitability and is 2.13%

Takeda Pharmaceutical Earnings Date & Stock Price

Takeda Pharmaceutical Competitors

Takeda Pharmaceutical Dividend Yield

Takeda Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: -15.82% 0%
Revenue: -2.19% 16.18%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 17.07
Upside from Last Price: 27.51%

Major Shareholders

  • How many TAK shares are owned by institutional investors?
    206.3M TAK shares are owned by institutional investors
  • How many TAK shares are owned by insiders?
    0 TAK shares are owned by insiders